Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency
- PMID: 11786103
- DOI: 10.1046/j.1523-1755.2002.00116.x
Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency
Abstract
Background: Increased concentrations of very low- (VLDL) and intermediate-density (IDL) lipoproteins in chronic renal failure (CRF) are thought to result from a defect(s) in degradation of plasma triglyceride (TG)-rich lipoproteins. The purpose of this study was to identify lipoprotein abnormalities associated with the reduced lipolytic rate constant, k1, of combined VLDL and IDL substrate from renal patients and asymptomatic controls.
Methods: The VLDL + IDL were isolated from 18 predialytic patients (CRF-I), 8 patients on hemodialysis (CRF-II) and 10 asymptomatic controls. The lipolytic rate constant (k1) of VLDL + IDL was measured by an assay using bovine milk lipoprotein lipase and determination of TG before and after incubation by gas chromatography (GC). Neutral lipids were measured by GC and apolipoproteins by electroimmunoassays; the apolipoprotein-defined TG-rich lipoproteins including Lp-B:C, Lp-B:C:E and Lp-A-II:B:C:D:E were determined by immunoaffinity chromatography.
Results: The k1 values of VLDL + IDL were significantly (P < 0.001) lower in CRF-I and CRF-II patients (0.0341 and 0.0352 min-1, respectively) than controls (0.0515 min-1). The levels of apolipoproteins B, C-III and E, and TG-rich Lp-B:C, Lp-B:C:E and Lp-A-II:B:C:D:E particles normalized to 100 mg TG per VLDL + IDL were significantly higher in both groups of CRF patients than in controls. All three TG-rich lipoproteins were characterized by significantly increased percent contents of free (FC) and esterified (CE) cholesterol and a decreased percentage of TG. The k1 values of the combined CRF-I and CRF-II patient groups showed significant negative correlations (P < 0.001) with FC (r=-0.81) and CE (r=-0.63) and a positive correlation with TG (r=0.72). Among lipoprotein particles, only Lp-A-II:B:C:D:E levels showed a significant negative correlation with k1 values (r=-0.47, P < 0.03).
Conclusions: This study shows that the abnormal neutral lipid composition of all three TG-rich lipoprotein particles and increased concentrations of Lp-A-II:B:C:D:E particles represent the main factors affecting the in vitro lipolytic rates of VLDL + IDL substrate in both the CRF patients before dialysis and patients on hemodialysis.
Similar articles
-
Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.Nephrol Dial Transplant. 1996 Jan;11(1):63-9. Nephrol Dial Transplant. 1996. PMID: 8649654
-
Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.Kidney Int. 1999 Apr;55(4):1536-42. doi: 10.1046/j.1523-1755.1999.00375.x. Kidney Int. 1999. PMID: 10201020
-
Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.Metabolism. 1994 Mar;43(3):333-47. doi: 10.1016/0026-0495(94)90102-3. Metabolism. 1994. PMID: 8139482
-
[Anomalies of lipoprotein metabolism in chronic renal insufficiency].Nephrologie. 1993;14(2):75-90. Nephrologie. 1993. PMID: 8327031 Review. French.
-
Atherogenic lipoproteins in end-stage renal disease.Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S30-3. doi: 10.1053/ajkd.2001.27393. Am J Kidney Dis. 2001. PMID: 11576918 Review.
Cited by
-
Predictors of incident albuminuria in the Framingham Offspring cohort.Am J Kidney Dis. 2010 Nov;56(5):852-60. doi: 10.1053/j.ajkd.2010.04.013. Am J Kidney Dis. 2010. PMID: 20599306 Free PMC article.
-
Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.Biomark Insights. 2007 Feb 7;1:185-92. Biomark Insights. 2007. PMID: 19690648 Free PMC article.
-
Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients.Nutrients. 2019 Nov 18;11(11):2820. doi: 10.3390/nu11112820. Nutrients. 2019. PMID: 31752189 Free PMC article. Review.
-
Dietary Lipids and Dyslipidemia in Chronic Kidney Disease.Nutrients. 2021 Sep 9;13(9):3138. doi: 10.3390/nu13093138. Nutrients. 2021. PMID: 34579015 Free PMC article. Review.
-
Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023.Front Pharmacol. 2024 Sep 3;15:1401939. doi: 10.3389/fphar.2024.1401939. eCollection 2024. Front Pharmacol. 2024. PMID: 39290864 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous